Two decades of resistance surveillance by the British Society for Antimicrobial Chemotherapy: design, development, delivery, deficiencies and future directions
Journal of Antimicrobial Chemotherapy · 2025
DOI: 10.1093/jac/dkaf247 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Antimicrobial Chemotherapy, 2025. Verfasst von Alasdair P MacGowan und 3 weiteren Autor:innen. Beteiligte Einrichtung: Bristol Centre for Antimicrobial Research and Evaluation (BCARE), Severn Infection Sciences, Pathology Sciences Building, North Bristol NHS Trust, So…. Hauptthemen laut MEDLINE: Anti-Bacterial Agents, Drug Resistance, Bacterial, Bacteria, Epidemiological Monitoring. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: British Society for Antimicrobial Chemotherapy, Abbott, Astellas.
Themen: Onkologische Pflege
Abstract (Originalsprache)
The British Society for Antimicrobial Chemotherapy Antimicrobial Surveillance Project was established in the United Kingdom (UK) and Ireland in response to dissatisfaction with existing antimicrobial surveillance which, in the 1990s, was fragmented and poorly informative for clinical and public heath purposes. The model developed into an integrated Project that was novel in its management and financing, being a true collaboration between a medical charity, pharmaceutical companies and the laboratories contracted to perform the testing. Separate ‘Programmes’ within an overall ‘Project’ collected and tested community- and hospital-acquired respiratory and bloodstream infection isolates. Cooperation with public sector bodies allowed data collection from the Project to be compared to routinely collected data from National Health Service laboratories. Between 1999 and 2019 the Project delivered test results on almost 100 000 isolates, from 17 bacterial genera to 44 antimicrobial agents. The results were made available annually on a specially constructed web site. In this supplement, we summarize the data collected in a series of papers relevant to the two programmes, discussing the Project’s strengths and deficiencies. Support for the Project declined in the period after 2010, and collection ceased after 20 years, its demise related to changing priorities within the partner organizations. However, the bacterial collection remains and is to be maintained to assist in future work in combating antimicrobial resistance.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Bristol Centre for Antimicrobial Research and Evaluation (BCARE), Severn Infection Sciences, Pathology Sciences Building, North Bristol NHS Trust, Southmead Hospital, Westbury-on-Trym, Bristol BS10 5NB, UK.
- Population Health Sciences, University of Bristol, Bristol BS8 2PS, UK.
- British Society for Antimicrobial Chemotherapy, 53 Regent Place, Birmingham B1 3NJ, UK.
- Division of Population Health and Genomics, School of Medicine, University of Dundee, Ninewells Hospital and Medical School, Dundee DD1 9SY, UK.
- Department of Medical Microbiology, Ninewells Hospital and Medical School, Dundee DD1 9SY, UK.
- Norwich Medical School, University of East Anglia, Norwich NR4 7TJ, UK.
Förderung
- British Society for Antimicrobial Chemotherapy
- Abbott
- Astellas
- AstraZeneca
- Aventis
- Basilea
- Bayer
- Cempra
Zitieren
APA
MacGowan, A. P., Reynolds, R., Parcell, B. J., & Livermore, D. M. (2025). Two decades of resistance surveillance by the British Society for Antimicrobial Chemotherapy: design, development, delivery, deficiencies and future directions. Journal of Antimicrobial Chemotherapy. https://doi.org/10.1093/jac/dkaf247
Vancouver
MacGowan AP, Reynolds R, Parcell BJ, Livermore DM. Two decades of resistance surveillance by the British Society for Antimicrobial Chemotherapy: design, development, delivery, deficiencies and future directions. Journal of Antimicrobial Chemotherapy. 2025. doi:10.1093/jac/dkaf247
BibTeX
@article{MacGowan2025,
author = {MacGowan, Alasdair P and Reynolds, Rosy and Parcell, Benjamin J and Livermore, David M},
title = {Two decades of resistance surveillance by the British Society for Antimicrobial Chemotherapy: design, development, delivery, deficiencies and future directions},
journal = {Journal of Antimicrobial Chemotherapy},
year = {2025},
doi = {10.1093/jac/dkaf247}
}
EUVIMED